This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/1710    most recent STROKEAHA.108.540138v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Earnshaw, S. R. Articles by Schwamm, L. Search for Related Content PubMed PubMed Citation Articles by Earnshaw, S. R. Articles by Schwamm, L. Related Collections Health policy and outcome research Cerebrovascular disease/stroke CT and MRI Computerized tomography and Magnetic Resonance Imaging Thrombolysis

(Stroke. 2009;40:1710.)
© 2009 American Heart Association, Inc.

Original Contributions

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis

Stephanie R. Earnshaw, PhD; Dan Jackson, MSc; Ray Farkouh, PhD Lee Schwamm, MD

From RTI Health Solutions (S.R.E., R.F.), Research Triangle Park, NC; GE Healthcare (D.J.), Chalfont St Giles, Buckinghamshire, UK; and the Department of Neurology (L.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Stephanie R. Earnshaw, RTI Health Solutions, PO Box 12194, Research Triangle Park, NC 27709. E-mail searnshaw{at}rti.org

Background and Purpose— Better selection of patients for intravenous recombinant tissue plasminogen activator (IV tPA) treatment may improve clinical outcomes. We examined the cost-effectiveness of adding penumbral-based MRI to usual computed tomography (CT)-based methods to identify patients for IV tPA treatment.

Methods— A decision-analytic model estimated the lifetime costs and outcomes associated with penumbral-based MRI selection in a patient population similar to that enrolled in the IV tPA clinical trials. Inputs were obtained from published literature, clinical trial data, claims databases, and expert opinion. Outcomes included cost per life-year saved and cost per quality-adjusted life-year (QALY) gained. Costs and outcomes were discounted at 3% annually. Sensitivity analyses were conducted.

Results— The addition of penumbral-based MRI selection increased total cost by $103 over the patient’s remaining lifetime. Penumbral-based MRI selection resulted in favorable outcomes (modified Rankin Scale 1) more often than CT-based selection (36.66% versus 35.06%) with an incremental cost per life year of $1840 and an incremental cost per QALY of $1004. Multivariate sensitivity analysis predicted cost-effectiveness ($50 000 per QALY) in 99.7% of simulation runs.

Conclusions— Selecting ischemic stroke patients for IV tPA treatment using penumbral-based MRI after routine CT may increase overall acute care costs, but the benefit is large enough to make this highly cost-effective. This economic analysis lends further support to the consideration of a paradigm shift in acute stroke evaluation.

Key Words: ischemic stroke • MRI • cost-effectiveness analysis • economics • stroke management